Connection
Vijaya Knight to Mycobacterium Infections, Nontuberculous
This is a "connection" page, showing publications Vijaya Knight has written about Mycobacterium Infections, Nontuberculous.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.462 |
|
|
|
-
Czaja CA, Merkel PA, Chan ED, Lenz LL, Wolf ML, Alam R, Frankel SK, Fischer A, Gogate S, Perez-Velez CM, Knight V. Rituximab as successful adjunct treatment in a patient with disseminated nontuberculous mycobacterial infection due to acquired anti-interferon-? autoantibody. Clin Infect Dis. 2014 Mar; 58(6):e115-8.
Score: 0.306
-
Honda JR, Knight V, Chan ED. Pathogenesis and risk factors for nontuberculous mycobacterial lung disease. Clin Chest Med. 2015 Mar; 36(1):1-11.
Score: 0.081
-
Ovrutsky AR, Merkel PA, Schonteich E, Bai X, Kinney W, Iseman MD, Kartalija M, Knight V, Chan ED. Patients with non-tuberculous mycobacterial lung disease have elevated transforming growth factor-beta following ex vivo stimulation of blood with live Mycobacterium intracellulare. Scand J Infect Dis. 2013 Sep; 45(9):711-4.
Score: 0.074